Navigating Regulatory Challenges in the U.S. Healthcare Market

If you are building a MedTech startup and targeting the U.S. market, guessing your regulatory pathway is not a strategy. This session breaks down device classification and FDA pathways, along with how to communicate early with FDA to confirm strategy, de-risk development, and build investor confidence. We also cover emerging focus areas, including cybersecurity, AI/ML, human factors, and QMS expectations aligned with ISO 13485. Designed specifically for startups, this presentation provides the clarity you need to move from concept to commercialization with fewer surprises.